
The AAA, CSAA, Microsoft and Motorola Solutions-backed emergency response software developer’s latest round, led by Insight Partners, brought its total funding to $200m.
The round brought the total raised by the oncology diagnostics technology developer, backed by Bristol Myers Squibb, Helsinn and Inova Health, to $244m.
Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.
The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.
GV returned for SpyBiotech's $32.5m series A round, as it looks to move its first potential vaccine into the clinic by early next year.
China Merchants Group participated in a series C-plus round for the cancer and inflammatory disease drug developer.
The probiotics developer secured an undisclosed amount as Cargill co-led the first close of a series D round with a $55m target.
Vienna Insurance is among the limited partners for a $48m seed-stage fund aimed at university spinouts in Austria.
Optum Ventures returned to invest in the telehealth software developer’s series A round, which was led by Venrock.
Tencent co-led online health services provider Yuanxin Technology's series E round with fellow existing investor Sequoia Capital China.